116 related articles for article (PubMed ID: 38685520)
1. PELI1 overexpression contributes to pancreatic cancer progression through upregulating ubiquitination-mediated INPP5J degradation.
Zhou W; Deng X; Liu L; Yuan Y; Meng X; Ma J
Cell Signal; 2024 Aug; 120():111194. PubMed ID: 38685520
[TBL] [Abstract][Full Text] [Related]
2. PELI1: key players in the oncogenic characteristics of pancreatic Cancer.
Fei X; Zhu C; Liu P; Liu S; Ren L; Lu R; Hou J; Gao Y; Wang X; Pan Y
J Exp Clin Cancer Res; 2024 Mar; 43(1):91. PubMed ID: 38528516
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of PELI1 caused by Jagged1 accelerates the malignant phenotype of pancreatic cancer.
Zhou W; Hu Y; Wang B; Yuan L; Ma J; Meng X
Cell Signal; 2023 Nov; 111():110877. PubMed ID: 37657587
[TBL] [Abstract][Full Text] [Related]
4. MiR-30c-5p loss-induced PELI1 accumulation regulates cell proliferation and migration via activating PI3K/AKT pathway in papillary thyroid carcinoma.
Zheng T; Zhou Y; Xu X; Qi X; Liu J; Pu Y; Zhang S; Gao X; Luo X; Li M; Wang X; Dong L; Wang Y; Mao C
J Transl Med; 2022 Jan; 20(1):20. PubMed ID: 34991623
[TBL] [Abstract][Full Text] [Related]
5. PELI1 functions as a dual modulator of necroptosis and apoptosis by regulating ubiquitination of RIPK1 and mRNA levels of c-FLIP.
Wang H; Meng H; Li X; Zhu K; Dong K; Mookhtiar AK; Wei H; Li Y; Sun SC; Yuan J
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):11944-11949. PubMed ID: 29078411
[TBL] [Abstract][Full Text] [Related]
6. PELI1 Selectively Targets Kinase-Active RIP3 for Ubiquitylation-Dependent Proteasomal Degradation.
Choi SW; Park HH; Kim S; Chung JM; Noh HJ; Kim SK; Song HK; Lee CW; Morgan MJ; Kang HC; Kim YS
Mol Cell; 2018 Jun; 70(5):920-935.e7. PubMed ID: 29883609
[TBL] [Abstract][Full Text] [Related]
7. SPOP suppresses pancreatic cancer progression by promoting the degradation of NANOG.
Tan P; Xu Y; Du Y; Wu L; Guo B; Huang S; Zhu J; Li B; Lin F; Yao L
Cell Death Dis; 2019 Oct; 10(11):794. PubMed ID: 31624231
[TBL] [Abstract][Full Text] [Related]
8. Peli1 contributes to myocardial ischemia/reperfusion injury by impairing autophagy flux via its E3 ligase mediated ubiquitination of P62.
Yang J; Tong T; Zhu C; Zhou M; Jiang Y; Chen H; Que L; Liu L; Zhu G; Ha T; Chen Q; Li C; Xu Y; Li J; Li Y
J Mol Cell Cardiol; 2022 Dec; 173():30-46. PubMed ID: 36179399
[TBL] [Abstract][Full Text] [Related]
9. LncRNA CARD8-AS1 suppresses lung adenocarcinoma progression by enhancing TRIM25-mediated ubiquitination of TXNRD1.
Pan C; Wang Q; Wang H; Deng X; Chen L; Li Z
Carcinogenesis; 2024 May; 45(5):311-323. PubMed ID: 38153696
[TBL] [Abstract][Full Text] [Related]
10. USP28 facilitates pancreatic cancer progression through activation of Wnt/β-catenin pathway via stabilising FOXM1.
Chen L; Xu Z; Li Q; Feng Q; Zheng C; Du Y; Yuan R; Peng X
Cell Death Dis; 2021 Sep; 12(10):887. PubMed ID: 34584067
[TBL] [Abstract][Full Text] [Related]
11. Peli1 impairs microglial Aβ phagocytosis through promoting C/EBPβ degradation.
Xu J; Yu T; Pietronigro EC; Yuan J; Arioli J; Pei Y; Luo X; Ye J; Constantin G; Mao C; Xiao Y
PLoS Biol; 2020 Oct; 18(10):e3000837. PubMed ID: 33017390
[TBL] [Abstract][Full Text] [Related]
12. HNF4α ubiquitination mediated by Peli1 impairs FAO and accelerates pressure overload-induced myocardial hypertrophy.
Hou Y; Shi P; Du H; Zhu C; Tang C; Que L; Zhu G; Liu L; Chen Q; Li C; Shao G; Li Y; Li J
Cell Death Dis; 2024 Feb; 15(2):135. PubMed ID: 38346961
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin ligase TRIM15 promotes the progression of pancreatic cancer via the upregulation of the IGF2BP2-TLR4 axis.
Cai H; Zhao J; Zhang Q; Wu H; Sun Y; Guo F; Zhou Y; Qin G; Xia W; Zhao Y; Liang X; Yin S; Qin Y; Li D; Wu H; Ren D
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167183. PubMed ID: 38657551
[TBL] [Abstract][Full Text] [Related]
14. PDIA6 promotes pancreatic cancer progression and immune escape through CSN5-mediated deubiquitination of β-catenin and PD-L1.
Ma Y; Xia P; Wang Z; Xu J; Zhang L; Jiang Y
Neoplasia; 2021 Sep; 23(9):912-928. PubMed ID: 34325342
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-induced feedback of HIF-1α and lncRNA-CF129 contributes to pancreatic cancer progression through stabilization of p53 protein.
Liu M; Zhong J; Zeng Z; Huang K; Ye Z; Deng S; Chen H; Xu F; Li Q; Zhao G
Theranostics; 2019; 9(16):4795-4810. PubMed ID: 31367258
[No Abstract] [Full Text] [Related]
16. Pellino 1 promotes lymphomagenesis by deregulating BCL6 polyubiquitination.
Park HY; Go H; Song HR; Kim S; Ha GH; Jeon YK; Kim JE; Lee H; Cho H; Kang HC; Chung HY; Kim CW; Chung DH; Lee CW
J Clin Invest; 2014 Nov; 124(11):4976-88. PubMed ID: 25295537
[TBL] [Abstract][Full Text] [Related]
17. CDK5/FBW7-dependent ubiquitination and degradation of EZH2 inhibits pancreatic cancer cell migration and invasion.
Jin X; Yang C; Fan P; Xiao J; Zhang W; Zhan S; Liu T; Wang D; Wu H
J Biol Chem; 2017 Apr; 292(15):6269-6280. PubMed ID: 28242758
[TBL] [Abstract][Full Text] [Related]
18. E3 ubiquitin ligase UBR5 promotes gemcitabine resistance in pancreatic cancer by inducing O-GlcNAcylation-mediated EMT via destabilization of OGA.
Du Y; Yang Z; Shi H; Chen Z; Chen R; Zhou F; Peng X; Hong T; Jiang L
Cell Death Dis; 2024 May; 15(5):340. PubMed ID: 38755129
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
20. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1.
Yang Y; Tao X; Li CB; Wang CM
Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
